Mirae Asset Global Investments Co. Ltd. Sells 39,005 Shares of DocGo Inc. (NASDAQ:DCGO)

Mirae Asset Global Investments Co. Ltd. reduced its position in DocGo Inc. (NASDAQ:DCGO) by 18.3% in the fourth quarter, HoldingsChannel.com reports. The firm owned 174,467 shares of the company’s stock after selling 39,005 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in DocGo were worth $975,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of DCGO. Arizona State Retirement System lifted its holdings in DocGo by 8.3% in the 3rd quarter. Arizona State Retirement System now owns 26,516 shares of the company’s stock worth $141,000 after purchasing an additional 2,042 shares in the last quarter. Worth Venture Partners LLC lifted its holdings in shares of DocGo by 36.3% in the third quarter. Worth Venture Partners LLC now owns 16,028 shares of the company’s stock worth $85,000 after buying an additional 4,265 shares in the last quarter. Principal Financial Group Inc. grew its stake in DocGo by 25.2% during the third quarter. Principal Financial Group Inc. now owns 25,591 shares of the company’s stock valued at $136,000 after acquiring an additional 5,154 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in DocGo by 42.5% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,020 shares of the company’s stock valued at $128,000 after acquiring an additional 7,166 shares during the last quarter. Finally, WINTON GROUP Ltd increased its position in shares of DocGo by 36.7% during the 3rd quarter. WINTON GROUP Ltd now owns 27,729 shares of the company’s stock valued at $148,000 after purchasing an additional 7,450 shares during the last quarter. 56.44% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on DCGO shares. Needham & Company LLC cut their price objective on shares of DocGo from $14.00 to $10.00 and set a “buy” rating on the stock in a research report on Thursday, February 29th. Cantor Fitzgerald cut their price target on shares of DocGo from $13.00 to $11.00 and set an “overweight” rating on the stock in a report on Thursday, February 29th. Canaccord Genuity Group decreased their price objective on shares of DocGo from $10.00 to $9.00 and set a “buy” rating for the company in a research note on Thursday, April 11th. Stifel Nicolaus cut their target price on DocGo from $11.00 to $8.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Finally, BTIG Research decreased their price target on DocGo from $13.00 to $11.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $10.83.

DocGo Price Performance

Shares of DCGO stock opened at $3.50 on Wednesday. The company has a market capitalization of $364.60 million, a P/E ratio of 50.00, a P/E/G ratio of 0.36 and a beta of 0.91. The company’s 50-day simple moving average is $3.72 and its two-hundred day simple moving average is $4.61. DocGo Inc. has a one year low of $2.78 and a one year high of $10.82.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings data on Wednesday, February 28th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.07). The firm had revenue of $199.25 million during the quarter, compared to the consensus estimate of $195.48 million. DocGo had a return on equity of 2.01% and a net margin of 1.10%. On average, research analysts expect that DocGo Inc. will post 0.35 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Michael J. Burdiek purchased 10,000 shares of the business’s stock in a transaction dated Thursday, March 14th. The shares were purchased at an average price of $3.61 per share, for a total transaction of $36,100.00. Following the completion of the purchase, the director now owns 571,595 shares in the company, valued at approximately $2,063,457.95. The purchase was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 13.78% of the company’s stock.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.